Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
- PMID: 27325861
- PMCID: PMC5019756
- DOI: 10.1200/JCO.2016.66.7196
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
Comment in
-
Reply to Yang et al and De Bari et al.J Clin Oncol. 2016 Aug 10;34(23):2799. doi: 10.1200/JCO.2016.67.7492. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325853 Free PMC article. No abstract available.
Comment on
-
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.J Clin Oncol. 2016 Feb 10;34(5):452-9. doi: 10.1200/JCO.2015.61.4925. Epub 2015 Nov 30. J Clin Oncol. 2016. PMID: 26628466 Free PMC article.
References
-
- Verslype C, Rosmorduc O, Rougier P. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii41–vii48. (suppl 7) - PubMed
-
- European Association for the Study of the Liver: EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. http://www.easl.eu/research/our-contributions/clinical-practice-guidelin....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
